• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布洛芬的潜在神经保护作用:来自帕金森病小鼠模型的研究。

Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.

机构信息

Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Krakowskie Przedmieście 26/28, PL 00-927 Warszawa, Poland.

出版信息

Pharmacol Rep. 2013;65(5):1227-36. doi: 10.1016/s1734-1140(13)71480-4.

DOI:10.1016/s1734-1140(13)71480-4
PMID:24399718
Abstract

BACKGROUND

Parkinson's disease (PD) is one of the most common neurodegenerative diseases. An inflammatory reaction seems to be involved in the pathological process in PD. Prospective clinical studies with various nonsteroidal anti-inflammatory drugs (NSAIDs) have shown that ibuprofen decreases the risk of PD. In the present study we investigated the influence of ibuprofen on dopaminergic neuron injury in the mice model of PD.

METHODS

Twelve-month-old male C57Bl mice were injected with MPTP together with various doses of ibuprofen (10, 30 or 50 mg/kg), administered 1 h before MPTP injection for 7 consecutive days. Evaluation concerned dopamine content in the striatum, tyrosine hydroxylase (TH) protein and α-synuclein expression measured 7 and 21 days post MPTP administration (dpa).

RESULTS

MPTP caused injury to dopaminergic neuron endings in the striatum: dopamine content decreased by about 0% 7 dpa and by 85% 21 dpa; TH protein expression diminished by 21% 7 dpa; α-synuclein level decreased by 10 and 26% 7 and 21 dpa, respectively. Ibuprofen administration to mice treated with MPTP significantly increased the level of dopamine in the striatum 7 and 21 dpa. It also prevented TH protein decrease and increased α-synuclein level 21 dpa.

CONCLUSIONS

Ibuprofen was shown to protect neurons against MPTP-induced injury in the striatum. The possible mechanism of the neuroprotective effect of ibuprofen might be associated with decreased dopamine turnover and cyclooxygenases inhibition resulting in lower reactive oxygen species formation.

摘要

背景

帕金森病(PD)是最常见的神经退行性疾病之一。炎症反应似乎参与了 PD 的病理过程。各种非甾体抗炎药(NSAIDs)的前瞻性临床研究表明,布洛芬可降低 PD 的发病风险。在本研究中,我们研究了布洛芬对 PD 小鼠模型中多巴胺能神经元损伤的影响。

方法

12 月龄雄性 C57Bl 小鼠接受 MPTP 联合不同剂量布洛芬(10、30 或 50mg/kg)注射,于 MPTP 注射前 1 小时连续 7 天给药。评估指标包括纹状体中的多巴胺含量、酪氨酸羟化酶(TH)蛋白和α-突触核蛋白表达,分别在 MPTP 给药后 7 天和 21 天进行测量。

结果

MPTP 导致纹状体多巴胺能神经元末梢损伤:多巴胺含量在 7 天和 21 天分别下降约 0%和 85%;TH 蛋白表达在 7 天下降 21%;α-突触核蛋白水平在 7 天和 21 天分别下降 10%和 26%。给予 MPTP 处理的小鼠布洛芬治疗显著增加了纹状体中多巴胺的水平在 7 天和 21 天。它还防止了 TH 蛋白减少和增加了 21 天的α-突触核蛋白水平。

结论

布洛芬显示出对纹状体中 MPTP 诱导的神经元损伤具有保护作用。布洛芬的神经保护作用的可能机制与其降低多巴胺周转率和抑制环氧化酶从而减少活性氧物质形成有关。

相似文献

1
Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease.布洛芬的潜在神经保护作用:来自帕金森病小鼠模型的研究。
Pharmacol Rep. 2013;65(5):1227-36. doi: 10.1016/s1734-1140(13)71480-4.
2
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.替米沙坦通过调节 C57BL/6J 小鼠中α-突触核蛋白和神经营养因子(BDNF 和 GDNF)的表达来减轻 MPTP 诱导的多巴胺能变性和运动功能障碍。
Neuropharmacology. 2013 Oct;73:98-110. doi: 10.1016/j.neuropharm.2013.05.025. Epub 2013 Jun 6.
3
Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.罗格列酮,一种过氧化物酶体增殖物激活受体-γ激动剂,可防止 6-羟多巴胺所致大鼠黑质纹状体多巴胺能神经元变性。
Toxicol Lett. 2012 Sep 18;213(3):332-44. doi: 10.1016/j.toxlet.2012.07.016. Epub 2012 Jul 27.
4
Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.联合使用 1-脱氧野尻霉素和布洛芬治疗可减少 MPTP 处理的小鼠中小胶质细胞的激活、吞噬作用和多巴胺能神经元变性。
J Neuroimmune Pharmacol. 2021 Jun;16(2):390-402. doi: 10.1007/s11481-020-09925-8. Epub 2020 Jun 21.
5
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.(±)-卡瓦因在帕金森病MPTP小鼠模型中的神经保护作用。
Synapse. 2001 Apr;40(1):47-54. doi: 10.1002/1098-2396(200104)40:1<47::AID-SYN1025>3.0.CO;2-S.
6
Neuroprotection in Parkinson models varies with toxin administration protocol.帕金森病模型中的神经保护作用因毒素给药方案而异。
Eur J Neurosci. 2006 Dec;24(11):3174-82. doi: 10.1111/j.1460-9568.2006.05192.x.
7
AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.AAV1/2 诱导的 A53T-α-突触核蛋白在黑质中的过表达导致具有路易小体样病理学和运动障碍的黑质纹状体系统变性:帕金森病的新小鼠模型。
Acta Neuropathol Commun. 2017 Feb 1;5(1):11. doi: 10.1186/s40478-017-0416-x.
8
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.利鲁唑(2-氨基-6-三氟甲氧基苯并噻唑)可减轻小鼠体内1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)的神经毒性。
Neurosci Lett. 2001 Oct 12;312(1):50-4. doi: 10.1016/s0304-3940(01)02176-0.
9
Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.鳞状酰胺衍生物FLZ在帕金森病的慢性MPTP/丙磺舒小鼠模型中保护酪氨酸羟化酶功能。
Naunyn Schmiedebergs Arch Pharmacol. 2015 May;388(5):549-56. doi: 10.1007/s00210-015-1094-5. Epub 2015 Feb 13.
10
Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.美洛昔康通过维持 Akt 信号通路改善帕金森病模型小鼠的运动功能障碍和多巴胺能神经退行性变。
Neurosci Lett. 2012 Jul 11;521(1):15-9. doi: 10.1016/j.neulet.2012.05.045. Epub 2012 May 19.

引用本文的文献

1
Neuroprotection in Parkinson Disease.帕金森病中的神经保护
Neurol Ther. 2025 Jul 18. doi: 10.1007/s40120-025-00793-z.
2
Microglial dynamics and neuroinflammation in prodromal and early Parkinson's disease.前驱期及早期帕金森病中的小胶质细胞动态变化与神经炎症
J Neuroinflammation. 2025 May 21;22(1):136. doi: 10.1186/s12974-025-03462-y.
3
Ibuprofen reduces inflammation, necroptosis and protects photoreceptors from light-induced retinal degeneration.布洛芬可减轻炎症、坏死性凋亡,并保护光感受器免受光诱导的视网膜变性。
J Neuroinflammation. 2025 Jan 28;22(1):20. doi: 10.1186/s12974-024-03329-8.
4
Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.日本帕金森病伴非运动症状患者的处方趋势:J-FIRST。
PLoS One. 2024 Oct 23;19(10):e0309297. doi: 10.1371/journal.pone.0309297. eCollection 2024.
5
Investigating the Effect of an Anti-Inflammatory Drug in Determining NURR1 Expression and Thus Exploring the Progression of Parkinson's Disease.研究一种抗炎药物在确定NURR1表达中的作用,从而探索帕金森病的进展。
Physiol Res. 2024 Mar 11;73(1):139-155. doi: 10.33549/physiolres.935168.
6
What Can Inflammation Tell Us about Therapeutic Strategies for Parkinson's Disease?炎症能告诉我们哪些关于帕金森病治疗策略的信息?
Int J Mol Sci. 2024 Jan 29;25(3):1641. doi: 10.3390/ijms25031641.
7
Anti-inflammatory Therapy Protects Spiral Ganglion Neurons After Aminoglycoside Antibiotic-Induced Hair Cell Loss.抗炎治疗可保护氨基糖苷类抗生素诱导毛细胞损失后的螺旋神经节神经元。
Neurotherapeutics. 2023 Mar;20(2):578-601. doi: 10.1007/s13311-022-01336-2. Epub 2023 Jan 25.
8
Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF-κB signaling pathways in peripheral monocytic cells.聚集的α-突触核蛋白在外周单核细胞中转录激活促炎经典和非经典 NF-κB 信号通路。
Mol Immunol. 2023 Feb;154:1-10. doi: 10.1016/j.molimm.2022.12.006. Epub 2022 Dec 24.
9
Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.帕金森病中的神经炎症及其治疗机会。
Balkan Med J. 2022 Sep 9;39(5):318-333. doi: 10.4274/balkanmedj.galenos.2022.2022-7-100. Epub 2022 Aug 29.
10
Therapeutic Strategies for Immune Transformation in Parkinson's Disease.帕金森病免疫治疗策略。
J Parkinsons Dis. 2022;12(s1):S201-S222. doi: 10.3233/JPD-223278.